This inventor holds 1 USPTO granted patent. Top assignee: Dso 'Pharmachim'. Active years: 1981.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981
Title: The Innovations of Kino D Andreev
Introduction
Kino D Andreev is a notable inventor based in Sofia, Bulgaria. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative methods of preparing chemical compounds. His work has led to the development of a patent that showcases his expertise and creativity in the field.
Latest Patents
Kino D Andreev holds a patent for a method of preparing 2-(phenylamino)-imidazolines. This process involves the preparation of compounds of a specific formula or their pharmaceutically acceptable salts. The method includes alkylating a compound with a specific formula, where the alkyl group can be a C1 to C4 alkyl or phenyl. This patent highlights his ability to create valuable chemical processes that can have significant applications in medicine.
Career Highlights
Throughout his career, Kino D Andreev has demonstrated a strong commitment to innovation in the pharmaceutical industry. He is currently associated with DSO 'Pharmachim', where he continues to work on developing new methods and compounds that can benefit the medical field. His dedication to research and development has positioned him as a key figure in his area of expertise.
Collaborations
Kino has collaborated with several talented individuals in his field, including Atanas G Georgiev and Kina V Konstantinova. These collaborations have allowed him to enhance his research and contribute to various projects that aim to advance pharmaceutical sciences.
Conclusion
Kino D Andreev's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts highlight his importance as an inventor. His work continues to pave the way for advancements in chemical processes that can lead to significant medical breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile